• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Medical Device Problem Codes Leak/Splash (1354); Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/20/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the balloon burst and was leaking.A 6.0 x 150mm, 150cm ranger paclitaxel-coated pta balloon catheter was selected for use in a percutaneous transluminal angioplasty procedure.The very calcified lesion was located in the superficial femoral artery.The balloon developed a leak and burst during the first inflation at 6 atm for 30 seconds, and never reached full size.The balloon was removed intact, and a second balloon of the same size was then advanced to the lesion and inflated.Shortly after inflation, the balloon began losing pressure and was removed.The procedure was completed with another ranger balloon.There were no patient complications.
 
Additional Manufacturer Narrative
Device eval by manufacturer: upon receipt at our post market quality assurance laboratory, this ranger paclitaxel-coated pta balloon catheter was visually and microscopically examined.Visual examination revealed a longitudinal tear to the balloon 8mm from the tip and was approximately 28mm long.Microscopic examination revealed no additional damages.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed there was a longitudinal tear in the balloon.
 
Event or Problem Description
It was reported that the balloon burst and was leaking.A 6.0 x 150mm, 150cm ranger paclitaxel-coated pta balloon catheter was selected for use in a percutaneous transluminal angioplasty procedure.The very calcified lesion was located in the superficial femoral artery.The balloon developed a leak and burst during the first inflation at 6 atm for 30 seconds, and never reached full size.The balloon was removed intact, and a second balloon of the same size was then advanced to the lesion and inflated.Shortly after inflation, the balloon began losing pressure and was removed.The procedure was completed with another ranger balloon.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17225425
Report Number2124215-2023-33934
Device Sequence Number7076152
Product Code ONU
UDI-Device Identifier08714729976189
UDI-Public08714729976189
Combination Product (Y/N)Y
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/08/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number06330H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/26/2023
Supplement Date Received by Manufacturer07/21/2023
Initial Report FDA Received Date06/29/2023
Supplement Report FDA Received Date07/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/09/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-